4.7 Article

Optimization of a Novel Binding Motif to (E)-3-(3,5-Difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 58, 期 20, 页码 8128-8140

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.5b00984

关键词

-

向作者/读者索取更多资源

The discovery of an orally bioavailable selective estrogen receptor downregulator (SEED) with equivalent. potency and preclinical pharmacology to the intramuscular SEED fulvestrant is described. A directed screen identified the 1-aryl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole motif as a novel, druglike ER ligand. Aided by crystal structures of novel ligands bound to an ER construct, medicinal chemistry iterations led to (E)-343,5-difluoro-44(1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido [3,4-b]-indol-1-yl)phenyl) acrylic acid (30b, AZD9496), a clinical candidate with high oral bioavailability across preclinical species that is currently being evaluated in phase I clinical trials for the treatment of advanced estrogen receptor (ER) positive breast cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Discovery of potent, selective small molecule inhibitors of α-subtype of type III phosphatidylinositol-4-kinase (PI4KIIIα)

Piotr Raubo, David M. Andrews, Jennifer C. McKelvie, Graeme R. Robb, James M. Smith, Martin E. Swarbrick, Michael J. Waring

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)

Review Pharmacology & Pharmacy

Compound Passport Service: supporting corporate collection owners in open innovation

David M. Andrews, Sebastien L. Degorce, David J. Drake, Magnus Gustafsson, Kevin M. Higgins, Jon J. Winter

DRUG DISCOVERY TODAY (2015)

Article Chemistry, Multidisciplinary

The creation and characterisation of a National Compound Collection: the Royal Society of Chemistry pilot

David M. Andrews, Laura M. Broad, Paul J. Edwards, David N. A. Fox, Timothy Gallagher, Stephen L. Garland, Richard Kidd, Joseph B. Sweeney

CHEMICAL SCIENCE (2016)

Article Chemistry, Medicinal

Design of a Biased Potent Small Molecule Inhibitor of the Bromodonnain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies

Niall Igoe, Elliott D. Bayle, Oleg Fedorov, Cynthia Tallant, Pavel Savitsky, Catherine Rogers, Dafydd R. Owen, Gauri Deb, Tim C. P. Somervaille, David M. Andrews, Neil Jones, Anne Cheasty, Hamish Ryder, Paul E. Brennan, Susanne Mueller, Stefan Knapp, Paul V. Fish

JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Chemistry, Medicinal

Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of Proteins

Niall Igoe, Elliott D. Bayle, Cynthia Tallant, Oleg Fedorov, Julia C. Meier, Pavel Savitsky, Catherine Rogers, Yannick Morias, Sarah Scholze, Helen Boyd, Danen Cunoosarny, David M. Andrews, Anne Cheasty, Paul E. Brennan, Susanne Mueller, Stefan Knapp, Paul V. Fish

JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Chemistry, Multidisciplinary

Potent, selective small molecule inhibitors of type III phosphatidylinositol-4-kinase α-but not β-inhibit the phosphatidylinositol signaling cascade and cancer cell proliferation

Michael J. Waring, David M. Andrews, Paul F. Faulder, Vikki Flemington, Jennifer C. McKelvie, Sarita Maman, Marian Preston, Piotr Raubo, Graeme R. Robb, Karen Roberts, Rachel Rowlinson, James M. Smith, Martin E. Swarbrick, Iris Treinies, Jon J. G. Winter, Robert J. Wood

CHEMICAL COMMUNICATIONS (2014)

Review Pharmacology & Pharmacy

Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface

David M. Andrews, Martin E. Swarbrick, Andrew T. Merritt

DRUG DISCOVERY TODAY (2014)

Article Chemistry, Medicinal

Protein-Ligand Crystal Structures Can Guide the Design of Selective Inhibitors of the FGFR Tyrosine Kinase

Richard A. Norman, Anne-Kathrin Schott, David M. Andrews, Jason Breed, Kevin M. Foote, Andrew P. Garner, Derek Ogg, Jonathon P. Orme, Jennifer H. Pink, Karen Roberts, David A. Rudge, Andrew P. Thomas, Andrew G. Leach

JOURNAL OF MEDICINAL CHEMISTRY (2012)

Article Multidisciplinary Sciences

Progress towards a public chemogenomic set for protein kinases and a call for contributions

David H. Drewry, Carrow I. Wells, David M. Andrews, Richard Angell, Hassan Al-Ali, Alison D. Axtman, Stephen J. Capuzzi, Jonathan M. Elkins, Peter Ettmayer, Mathias Frederiksen, Opher Gileadi, Nathanael Gray, Alice Hooper, Stefan Knapp, Stefan Laufer, Ulrich Luecking, Michael Michaelides, Susanne Mueller, Eugene Muratov, R. Aldrin Denny, Kumar S. Saikatendu, Daniel K. Treiber, William J. Zuercher, Timothy M. Willson

PLOS ONE (2017)

Article Biochemistry & Molecular Biology

The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification

Carrow I. Wells, Hassan Al-Ali, David M. Andrews, Christopher R. M. Asquith, Alison D. Axtman, Ivan Dikic, Daniel Ebner, Peter Ettmayer, Christian Fischer, Mathias Frederiksen, Robert E. Futrell, Nathanael S. Gray, Stephanie B. Hatch, Stefan Knapp, Ulrich Luecking, Michael Michaelides, Caitlin E. Mills, Susanne Mueller, Dafydd Owen, Alfredo Picado, Kumar S. Saikatendu, Martin Schroeder, Alexandra Stolz, Mariana Tellechea, Brandon J. Turunen, Santiago Vilar, Jinhua Wang, William J. Zuercher, Timothy M. Willson, David H. Drewry

Summary: The chemogenomic set of protein kinase inhibitors described in this study is a valuable open science resource for studying kinase biology, consisting of 187 inhibitors that target 215 human kinases. It is highly annotated and selective, making it a useful tool for researchers in cell-based screens.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Identification and optimization of a novel series of selective PIP5K inhibitors

David M. Andrews, Sharon Cartic, Sabina Cosulich, Nullin Divecha, Paul Faulder, Vikki Flemington, Oliver Kern, Jason G. Kettle, Ellen MacDonald, Jennifer McKelvie, Kurt G. Pike, Bryan Roberts, Rachel Rowlinson, James M. Smith, Martin Stockley, Martin E. Swarbrick, Iris Treinies, Michael J. Waring

Summary: A novel and highly specific inhibitor of PIP5K has been discovered, which demonstrates potent biochemical and cellular activity, providing valuable insight into the role of PIP5K in human cancers.

BIOORGANIC & MEDICINAL CHEMISTRY (2022)

Article Chemistry, Multidisciplinary

From peptides to proteins: coiled-coil tetramers to single-chain 4-helix bundles

Elise A. Naudin, Katherine Albanese, Abigail J. Smith, Bram Mylemans, Emily G. Baker, Orion D. Weiner, David M. Andrews, Natalie Tigue, Nigel J. Savery, Derek N. Woolfson

Summary: By analyzing known antiparallel 4-helix coiled-coil structures, we identified design rules and applied them in the rational design of synthetic peptides to form antiparallel homo- and heterotetramers. Ultimately, we used the sequence of the homotetramer to derive a single-chain 4-helix-bundle protein for recombinant production in E. coli in one step.

CHEMICAL SCIENCE (2022)

Article Chemistry, Multidisciplinary

Query-guided protein-protein interaction inhibitor discovery

Sergio Celis, Fruzsina Hobor, Thomas James, Gail J. Bartlett, Amaurys A. Ibarra, Deborah K. Shoemark, Zsofia Hegedus, Kristina Hetherington, Derek N. Woolfson, Richard B. Sessions, Thomas A. Edwards, David M. Andrews, Adam Nelson, Andrew J. Wilson

Summary: The study presents a general approach to discover orthosteric PPI inhibitors that mimic specific secondary protein structures, validated through experimental examples. Low μM activity selective PPI inhibitors were discovered for two unrelated PPIs, with defined structure-activity relationships established through hit expansion. The approach is believed to have the potential to enable the discovery of inhibitors for a wide range of unrelated secondary structure-mediated PPIs.

CHEMICAL SCIENCE (2021)

Article Biochemistry & Molecular Biology

Identification and Characterization of Dual Inhibitors of the USP25/28 Deubiquitinating Enzyme Subfamily

Jonathan D. Wrigley, Gerald Gavory, Iain Simpson, Marian Preston, Helen Plant, Jenna Bradley, Anne U. Goeppert, Ewelina Rozycka, Gareth Davies, Jarrod Walsh, Andrea Valentine, Keeva McClelland, Krzysztofa Ewa Odrzywol, Jonathan Renshaw, Joanna Boros, Jonathan Tart, Lindsey Leach, Thorsten Nowak, Richard A. Ward, Timothy Harrison, David M. Andrews

ACS CHEMICAL BIOLOGY (2017)

暂无数据